RecruitingNot Applicable

PRESS -PAR: Early Detection and PREvention of Symptomatic postSurgical hypoPARathyroidism After Thyroid Surgery"

Germany336 participantsStarted 2025-01-08

Plain-language summary

This study aims to investigate whether an earlier measurement of parathyroid hormone can reduce the number of patients who develop symptomatic hypoparathyroidism. This will provide evidence for a clear algorithm to address this issue after thyroid surgery. It will lead to an improvement in quality of life and a reduction in the distress experienced by affected patients. In addition, it is conceivable that patients' hospital stay could be shortened.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years * Thyroidectomy or bilateral thyroid resection of any indication * Written informed consent obtained after detailed patient information and provision of an information sheet Exclusion Criteria: * Age ≤ 18 years * Concomitant parathyroid disease (primary or secondary hyperparathyroidism, pre-existing hypoparathyroidism of any cause) * Previous surgery in the neck region * Pregnancy or breastfeeding * Inability to attend study visits * Participation in another study that interferes with the endpoints * Missing or inadequate patient information

What they're measuring

Symptomatic hypoparathyroidism (symptom score) with hypocalcemia

Timeframe: within hospital stay (0-48hours after bilateral thyroid surgery)

Trial details

NCT IDNCT07491601

SponsorNicolas Schlegel

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-12-31

Contact for this trial

Nicolas Schlegel, Prof. Dr. (MD)

+49 931 201 38217 SCHLEGEL_N@ukw.de

View on ClinicalTrials.gov More Postoperative Hypoparathyroidism trials